Erik A Dienemann

Title: The Innovations of Erik A Dienemann

Introduction

Erik A Dienemann is a notable inventor based in Metuchen, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on innovative formulations and methods that enhance the effectiveness of pharmaceutical compositions.

Latest Patents

One of Erik's latest patents involves formulations of suberoylanilide hydroxamic acid and methods for producing the same. This invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile. It comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The invention also outlines a process for producing said crystalline composition or pharmaceutical composition, along with compositions that feature a specific particle size distribution.

Career Highlights

Throughout his career, Erik has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and delivery.

Collaborations

Erik has collaborated with talented individuals in his field, including Jeannie Chow Wong and Aaron S Cote. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Erik A Dienemann's contributions to pharmaceutical innovations demonstrate his commitment to improving drug formulations and delivery methods. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.